CFDB - Cystic Fibrosis DataBase

at least one term
all terms

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis - Phase 2|Phase 3 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • Wake Forest University Health Sciences|Emory University|University of Minnesota|University of Texas Southwestern Medical Center

The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement

ongoing trials  trial from other registries

Details
  • 2022

Evaluation the effects of camel milk in spirometry parameters in over 6 year’s children with Cystic Fibrosis lung disease - Recruiting

ongoing trials  trial from other registries

Details
  • 2022

Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis - Phase 2 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • University of Kansas Medical Center

Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation - Phase 3 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • Vertex Pharmaceuticals Incorporated

Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF - Phase 4 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • Hospital Infantil de Mexico Federico Gomez

A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes

ongoing trials  trial from other registries

Details
  • 2021

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

ongoing trials  trial from other registries

Details
  • 2021

A Phase 3 Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy and Safety of ELX/TEZ/IVA in Cystic Fibrosis Subjects 6 Years of Age and Older With a Non-F508del ELX/TEZ/IVA-responsive CFTR Mutation

ongoing trials  trial from other registries

Details
  • 2021

CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) - Phase 1|Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • Yale University